Back
IBBIS - International Biosecurity and Biosafety Initiative for Science
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
IBBIS is relevant to AI safety discussions because AI-enabled biosecurity threats are considered among the most severe near-term catastrophic risks; understanding biosecurity governance frameworks informs how AI capabilities in biology should be regulated.
Metadata
Importance: 42/100homepage
Summary
IBBIS is an international organization focused on strengthening biosecurity and biosafety for the life sciences. It works to prevent misuse of biological research by developing screening tools, standards, and governance frameworks for the scientific community. The organization aims to reduce biosecurity risks while enabling beneficial scientific progress.
Key Points
- •IBBIS develops and promotes nucleic acid synthesis screening tools to prevent dangerous biological materials from being created by bad actors
- •The organization works with governments, industry, and scientific institutions to establish biosecurity norms and standards
- •IBBIS focuses on the intersection of life sciences governance and biosecurity risk reduction relevant to catastrophic biological risks
- •It represents a coordination effort to address dual-use research concerns across the global scientific community
- •Relevant to AI safety as AI-enabled bioweapon design is considered a major catastrophic risk from advanced AI systems
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20263 KB
About - IBBIS
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
"IBBIS is a necessary institution and fills a critical gap in the global architecture for responsible stewardship of science."
- Dr. Margaret A. Hamburg, Former FDA Commissioner
"IBBIS is a necessary institution and fills a critical gap in the global architecture for responsible stewardship of science."
- Dr. Margaret A. Hamburg, Former FDA Commissioner
Our Vision
A world in which bioscience and biotechnology can advance and flourish safely and responsibly.
Our Mission
The International Biosecurity and Biosafety Initiative for Science (IBBIS) works collaboratively with global partners to strengthen biosecurity norms and develop innovative tools to uphold them. We undertake this work to safeguard science and reduce the risk of catastrophic events that could result from deliberate abuse or accidental misuse of bioscience and biotechnology.
Our Work
IBBIS is the only independent organization with a primary mission dedicated to reducing emerging biological risks associated with technology advances. We address risk-reduction opportunities throughout the bioscience research and development lifecycle to incorporate effective risk-reduction practices at every stage — from project conceptualization and funding, through research execution, and on to publication or commercialization.
Currently, our work focuses on mapping where synthetic DNA is being made; providing tools so that anyone, anywhere can screen what is being ordered and by whom; and supporting global biosecurity through international standards, regional policy dialogues, and industry best practices.
Our History
In 2019, NTI | bio and international stakeholders identified the need for an organization dedicated to reducing emerging biological risks associated with technology advances. NTI | bio then incubated IBBIS in preparation for its establishment and helped it develop new biosecurity tools, eventually appointing Dr. Piers Millett as the inaugural executive director of IBBIS in the fall of 2022. Throughout 2023 IBBIS and its tools were developed and readied for launch. IBBIS was launched in February 2024, released its DNA synthesis screening tool in May 2024, and was accepted as a non-profit foundation with a public-good mission in June 2024. As of January 2025, IBBIS has taken ownership o
... (truncated, 3 KB total)Resource ID:
7d0b2256cbf8f864 | Stable ID: sid_5pEpJ7ntTA